Cortisol in the Treatment of Phobias

University of Zurich (UZH)

Status: Completed

Conditions: Phobia

Treatments: Drug: Cortisol

Study type: Interventional

Funder types: Other

Identifiers

NCT00451750

2007DR3069

Details and patient eligibility

About

The aim of this prospective, double-blind, placebo-controlled, randomized study is to investigate if glucocorticoid treatment, in combination with exposure therapy, helps to reduce phobic fear in patients with phobia.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female and male patients with a specific phobia (fear of heights) according to DSM-IV criteria.

Exclusion criteria

• Severe acute or chronic somatic diseases
• Psychiatric disorder other than specific phobia
• Topic glucocorticoid therapy (for large skin parts)
• Inhaled glucocorticoids
• Psychotropic medication
• Pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind